The purpose of this study is to assess the efficacy and safety of T2345 versus active
comparator.

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

Glaucoma

T2345

Prostaglandin

The worse eye is defined as:

  -  If both eyes are eligible the eye with highest Intraocular pressure (IOP) at Day 0
     (D0). If both eyes have the same IOP at D0 the worse eye is the right eye.

  -  If only one eye is eligible this eye is the worse eye.

  -  If neither eye is eligible the worse eye is defined as the eye with the highest IOP
     at D0.

If both eyes have the same IOP at D0 the worse eye is the right eye.

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status